Skip to main content

Irene Hernández Hernández

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Irene Hernández Hernández

Irene Hernández Hernández

Irene Hernández Hernández

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs

IP: José Raul Herance Camacho
Collaborators: Fiorella Dellepiane Clarke, Joan Castell Conesa, Nuria Roson Gradaille, Carolina Aparicio Gomez, Alberto Roque Pérez, Mònica Velasco Nuño, Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs, Irene Hernández Hernández, Maria Nazarena Pizzi, Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI20/01588
Duration: 01/01/2021 - 30/06/2025

Role of sarcopenia in the evolution of morbidly obese patients who undergo bariatric surgery. Study of cohorts and mechanisms involved.

IP: Andreea Ciudin Mihai
Collaborators: Oscar González López, Fiorella Ximena Palmas Candia, Marina Giralt Arnaiz, Marta Comas Martínez, Rosa Burgos Peláez, Irene Hernández Hernández, Enzamaría Fidilio Meli, Efráin Santiago Cordero Vázquez, Cristina Gamez Cenzano
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01086
Duration: 01/01/2021 - 31/12/2024

Control of the adipose-pancreatic crosstalk by mitochondrial metabolism in adipose tissues: implications in the development of diet-induced type 2 diabetes

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz, Berta Pares Bofill, Irene Hernández Hernández
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 145200
Reference: RTI2018-099250-B-I00
Duration: 01/01/2019 - 30/09/2022

Related news

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

The study will validate the safety of a novel topical ocular administration route for sitagliptin.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Nuria  Roson  Gradaille

Nuria Roson Gradaille

Research technician
Molecular Imaging and Therapy
Read more
Sonia Terradas Campanario

Sonia Terradas Campanario

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Teresa Soriano Sánchez

Teresa Soriano Sánchez

Cardiovascular Diseases
Read more
Joan Roig Sanchís

Joan Roig Sanchís

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.